VF
ARMP icon

Virtu Financial’s Armata Pharmaceuticals ARMP Stock Holding History

Virtu Financial’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,269
Closed -$31K – 1441
2019
Q1 		$31K Buy
7,269
+1,090
+18% +$4.14K ﹤0.01% 1258
2018
Q4 		$17K Buy
6,179
+3,020
+96% +$14.7K ﹤0.01% 1389
2018
Q3 		$45K Buy
3,159
+1,949
+161% +$28.4K ﹤0.01% 1314
2018
Q2 		$19K Sell
1,210
-2,763
-70% -$45K ﹤0.01% 1863
2018
Q1 		$61K Buy
3,973
+1,980
+99% +$35.1K ﹤0.01% 1673
2017
Q4 		$28K Sell
1,993
-1,123
-36% -$16.6K ﹤0.01% 2169
2017
Q3 		$40K Buy
+3,116
New +$39.9K ﹤0.01% 2257

Other funds holding ARMP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's ARMP Position: Q2 2019 in Review

Virtu Financial sold out of Armata Pharmaceuticals (ARMP) in Q2 2019, closing a stake of 7,269 shares — an estimated $31K sold.

Virtu Financial first reported a position in ARMP in Q3 2017 and held it in 7 quarters. The position peaked at $61K in Q1 2018. 12 funds tracked by Wall St. Rank hold ARMP as of Q2 2019.

  • Virtu Financial reported no remaining Armata Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Virtu Financial sold 7,269 Armata Pharmaceuticals shares in Q2 2019, an estimated $31K.
  • Virtu Financial first reported a position in Armata Pharmaceuticals in Q3 2017 and held it in 7 quarters.
  • Virtu Financial's Armata Pharmaceuticals position peaked at $61K in Q1 2018.
  • 12 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2019.

Based on Virtu Financial's 13F filing for Q2 2019, filed 13 Aug 2019.